This paper is in the following e-collection/theme issue:

Design and Formative Evaluation of Mobile Apps (732) mHealth for Symptom and Disease Monitoring, Chronic Disease Management (1524) Alcohol Abuse, Alcoholism Prevention and Recovery (315) Anxiety and Stress Disorders (1146) Dementia and Cognitive Decline (558) Depression and Mood Disorders; Suicide Prevention (1477) Mobile Health in Psychiatry (467) Stroke (187) Neurotechnology in Clinical Studies (16)

Published on in Vol 8, No 8 (2020): August

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/16180, first published .
Characteristics of Neuropsychiatric Mobile Health Trials: Cross-Sectional Analysis of Studies Registered on ClinicalTrials.gov

Characteristics of Neuropsychiatric Mobile Health Trials: Cross-Sectional Analysis of Studies Registered on ClinicalTrials.gov

Characteristics of Neuropsychiatric Mobile Health Trials: Cross-Sectional Analysis of Studies Registered on ClinicalTrials.gov

Authors of this article:

Mia Tova Minen1 Author Orcid Image ;   Julia Frederica Reichel2 Author Orcid Image ;   Pallavi Pemmireddy2 Author Orcid Image ;   Elizabeth Loder3 Author Orcid Image ;   John Torous4 Author Orcid Image
Article Authors Cited by (3) Tweetations (2) Metrics

Journals

  1. Maru S, Kuwatsuru R, Matthias M, Simpson Jr R. Public Disclosure of Results From Artificial Intelligence/Machine Learning Research in Health Care: Comprehensive Analysis of ClinicalTrials.gov, PubMed, and Scopus Data (2010-2023). Journal of Medical Internet Research 2025;27:e60148 View
  2. Lin B, Guo X, Jiang Y, Shang-Guan Z, Zhong Q, Chen Q, Xie J, Li P, Zheng C, Huang C, Lin J. Characterization changes and research waste in randomized controlled trials of global gastroesophageal reflux disease and hiatus hernia over the past 20 years. International Journal of Surgery 2025;111(3):2358 View

Books/Policy Documents

  1. Sherer J, Richman E, Shalvoy K. Technology-Assisted Interventions for Substance Use Disorders. View